NR1H4 and diabetic retinopathy: TGR5, a bile acid receptor, has been previously reported to activate PKA signaling by increasing intracellular cAMP levels, and activation of TGR5 receptors can relive diabetic retinopathy by inhibiting the RhoA/ROCK pathway [28, 29].